GLP-1 agonists primarily cause gastrointestinal side effects
Funding The Atherosclerosis Risk in Communities study has been funded in whole or in part with Federal funds from the National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services, under contract numbers 75N92022D00001, 75N92022D00002, 75N92022D00003, 75N92022D00004 and 75N92022D00005
In practical terms: Saxenda users are less likely to experience hair shedding than Ozempic or Mounjaro users, likely because liraglutide tends to produce slower, more modest weight loss that places less acute stress on the body
However, although polysomnographic studies have suggested that DSIP may induce statistically significant improvement in sleep, sufficient research material is still weak
General Physiology 9, 715725
And so they they are are being deployed now, and theres a lot of interest there